Show simple item record

dc.contributor.authorBrakoulias, Vlasios
dc.contributor.authorStarcevic, Vladan
dc.contributor.authorAlbert, Umberto
dc.contributor.authorArumugham, Shyam Sundar
dc.contributor.authorBailey, Brenda E
dc.contributor.authorBelloch, Amparo
dc.contributor.authorBorda, Tania
dc.contributor.authorDell'Osso, Liliana
dc.contributor.authorElias, Jason A
dc.contributor.authorFalkenstein, Martha J
dc.contributor.authorFerrao, Ygor A
dc.contributor.authorFontenelle, Leonardo F
dc.contributor.authorJelinek, Lena
dc.contributor.authorKalogeraki, Leto
dc.contributor.authorKay, Brian
dc.contributor.authorLaurito, Luana D
dc.contributor.authorLochner, Christine
dc.contributor.authorMaina, Giuseppe
dc.contributor.authorMarazziti, Donatella
dc.contributor.authorMartin, Andrew
dc.contributor.authorMatsunaga, Hisato
dc.contributor.authorMiguel, Euripedes C
dc.contributor.authorMorgado, Pedro
dc.contributor.authorMourikis, Irakis
dc.contributor.authorPasquini, Massimo
dc.contributor.authorPerez Rivera, Rodrigo
dc.contributor.authorPotluri, Sriramya
dc.contributor.authorReddy, Janardhan Y C
dc.contributor.authorRiemann, Brian C
dc.contributor.authordo Rosario, Maria Conceição
dc.contributor.authorShavitt, Roseli G
dc.contributor.authorStein, Dan J
dc.contributor.authorViswasam, Kirupumani
dc.contributor.authorWang, Zhen
dc.contributor.authorFineberg, Naomi A
dc.date.accessioned2019-08-07T01:12:26Z
dc.date.available2019-08-07T01:12:26Z
dc.date.issued2019-01-10
dc.identifier.citationBrakoulias , V , Starcevic , V , Albert , U , Arumugham , S S , Bailey , B E , Belloch , A , Borda , T , Dell'Osso , L , Elias , J A , Falkenstein , M J , Ferrao , Y A , Fontenelle , L F , Jelinek , L , Kalogeraki , L , Kay , B , Laurito , L D , Lochner , C , Maina , G , Marazziti , D , Martin , A , Matsunaga , H , Miguel , E C , Morgado , P , Mourikis , I , Pasquini , M , Perez Rivera , R , Potluri , S , Reddy , J Y C , Riemann , B C , do Rosario , M C , Shavitt , R G , Stein , D J , Viswasam , K , Wang , Z & Fineberg , N A 2019 , ' Treatments used for obsessive-compulsive disorder-An international perspective ' , Human Psychopharmacology , vol. 34 , no. 1 , e2686 , pp. e2686 . https://doi.org/10.1002/hup.2686
dc.identifier.issn0885-6222
dc.identifier.otherPURE: 16664494
dc.identifier.otherPURE UUID: f5610594-cc17-4d12-895b-4f3ab6297129
dc.identifier.otherPubMed: 30628745
dc.identifier.otherScopus: 85059870802
dc.identifier.urihttp://hdl.handle.net/2299/21550
dc.description© 2019 John Wiley & Sons, Ltd.
dc.description.abstractOBJECTIVE: The objective of this study was to characterise international trends in the use of psychotropic medication, psychological therapies, and novel therapies used to treat obsessive-compulsive disorder (OCD). METHODS: Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their samples. Consistency of summary statistics across countries was evaluated. RESULTS: The study surveyed 19 expert centres from 15 countries (Argentina, Australia, Brazil, China, Germany, Greece, India, Italy, Japan, Mexico, Portugal, South Africa, Spain, the United Kingdom, and the United States) providing a total sample of 7,340 participants. Fluoxetine (n = 972; 13.2%) and fluvoxamine (n = 913; 12.4%) were the most commonly used selective serotonin reuptake inhibitor medications. Risperidone (n = 428; 7.3%) and aripiprazole (n = 415; 7.1%) were the most commonly used antipsychotic agents. Neurostimulation techniques such as transcranial magnetic stimulation, deep brain stimulation, gamma knife surgery, and psychosurgery were used in less than 1% of the sample. There was significant variation in the use and accessibility of exposure and response prevention for OCD. CONCLUSIONS: The variation between countries in treatments used for OCD needs further evaluation. Exposure and response prevention is not used as frequently as guidelines suggest and appears difficult to access in most countries. Updated treatment guidelines are recommended.en
dc.language.isoeng
dc.relation.ispartofHuman Psychopharmacology
dc.subjectantipsychotics
dc.subjectbenzodiazepines
dc.subjectcross-cultural study
dc.subjectobsessive–compulsive disorder
dc.subjectpharmacotherapy
dc.subjectselective serotonin reuptake inhibitors
dc.subjectNeurology
dc.subjectClinical Neurology
dc.subjectPsychiatry and Mental health
dc.subjectPharmacology (medical)
dc.titleTreatments used for obsessive-compulsive disorder-An international perspectiveen
dc.contributor.institutionCognitive Neuropsychology
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionSchool of Life and Medical Sciences
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85059870802&partnerID=8YFLogxK
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1002/hup.2686
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record